骨量-肌量减少性肥胖与心血管疾病相关性研究进展

doi:10.3969/j.issn.1003-9198.2026.08.019

摘要/Abstract

摘要： 骨量-肌量减少性肥胖综合征(OSO)近年来备受关注。该综合征不仅影响个体的骨骼和肌肉健康,还与心血管疾病的发生和发展密切相关。本文从OSO的诊断、流行病学特征,OSO与心血管疾病的关联机制及相关性临床证据进行综述,提出未来还需要建立OSO的统一诊断标准,将OSO相关指标纳入心血管疾病风险评估与管理,强化OSO与心血管疾病的共同病理机制与危险因素的研究,最终构建科学、系统的诊疗体系。

关键词: 骨量-肌量减少性肥胖, 心血管疾病, 骨质疏松, 肌少症, 肥胖

Abstract: Osteosarcopenic obesity syndrome (OSO) has attracted much attention in recent years. This syndrome not only affects an individual’s bone and muscle health, but also closely related to the occurrence and development of cardiovascular diseases. This article reviews the diagnosis and epidemiological characteristics of OSO, the association mechanism between OSO and cardiovascular diseases, as well as relevant clinical evidence. It proposes that in the future, a unified diagnostic standard for OSO should be established, OSO-related indicators should be incorporated into cardiovascular disease risk assessment and management, and research on the shared pathological mechanisms and risk factors between OSO and cardiovascular diseases should be strengthened, ultimately aiming to construct a scientific and systematic diagnosis and treatment system.

Key words: osteosarcopenic obesity, cardiovascular diseases, osteoporosis, sarcopenia, obesity

中图分类号:

R 592
R 54

卜祥慧, 杨伟, 杨申申, 邓婷, 赵媛, 王伟华. 骨量-肌量减少性肥胖与心血管疾病相关性研究进展[J]. 实用老年医学, 2026, 40(8): 855-859.

BU Xianghui, YANG Wei, YANG Shenshen, DENG Ting, ZHAO Yuan, WANG Weihua. Research progress on the association between osteosarcopenic obesity and cardiovascular diseases[J]. Practical Geriatrics, 2026, 40(8): 855-859.

参考文献

[1] 万家敏, 赵柯湘, 孙悦, 等. 骨量-肌量减少性肥胖综合征与2型糖尿病关系的研究进展[J]. 中国全科医学, 2021, 24(9): 1152-1157.
[2] ILICH J Z, KELLY O J, INGLIS J E, et al.Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels[J]. Ageing Res Rev, 2014, 15: 51-60.
[3] 聂义珍, 闫朝岐, 燕巍, 等. 基于多元统计学方法的骨量肌量减少性肥胖综合征的结构特征研究[J]. 中国全科医学, 2022, 25(22): 2733-2739, 2745.
[4] 吕婷, 王晓云, 郑彭燕, 等. 老年人骨量-肌量减少性肥胖综合征患病率的Meta分析[J]. 中华临床营养杂志, 2026, 34(1): 27-34.
[5] PANG B W J, WEE S L, CHEN K K, et al. Coexistence of osteoporosis, sarcopenia and obesity in community-dwelling adults-The Yishun Study[J].Osteoporos Sarcopenia, 2021, 7(1):17-23.
[6] KUCHI BHOTLA H, MEYYAZHAGAN A, PUSHARAJ K, et al. Prevalence of cardiovascular diseases in South Asians: scrutinizing traditional risk factors and newly recognized risk factors sarcopenia and osteopenia/osteoporosis[J].Curr Probl Cardiol, 2024, 49(1 Pt B):102071.
[7] 张欣, 代火祥, 黄丽红. 心力衰竭与骨质疏松相关性的研究进展[J]. 中国心血管杂志, 2025, 30(5): 607-612.
[8] 李艳琪, 宋艳萍, 姚娜, 等. 骨量肌量减少性肥胖研究热点及趋势的可视化研究[J]. 运动科学与健康研究, 2025(4): 34-44.
[9] 盛丽春, 高静媛, 王明兰, 等. 骨量-肌量减少性肥胖综合征的研究进展[J]. 中国现代医生, 2024, 62(17): 118-121, 124.
[10] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2022, 15(6): 573-611.
[11] 中华医学会老年医学分会, 国家老年疾病临床医学研究中心(湘雅医院). 中国肌肉减少症诊疗指南(2024版)[J]. 中华医学杂志, 2025, 105(03): 181-203.
[12] 曲伸, 陆灏, 宋勇峰. 基于临床的肥胖症多学科诊疗共识(2021年版)[J]. 中华肥胖与代谢病电子杂志, 2021, 7(4): 211-226.
[13] LIU Y, SONG Y, HAO Q, et al. Global prevalence of osteosarcopenic obesity amongst middle aged and older adults: a systematic review and meta-analysis[J]. Arch Osteoporos, 2023, 18(1): 60.
[14] MA Y, ZHANG W, HAN P, et al.Osteosarcopenic obesity associated with poor physical performance in the elderly Chinese community[J]. Clin Interv Aging, 2020, 15: 1343-1352.
[15] MO D, HSIEH P, YU H, et al.Osteosarcopenic obesity and its relationship with dyslipidemia in women from different ethnic groups of China[J]. Arch Osteoporos, 2018, 13(1): 65.
[16] LIM H S, KIM D K, GIL H I, et al. Association of pulmonary function with osteosarcopenic obesity in older adults aged over 50 years[J]. Nutrients, 2023, 15(13): 2933.
[17] CHUCHERD O, VALLIBHAKARA O, VALLIBHAKARA S A, et al. Association of sarcopenic obesity and osteoporosis in postmenopausal women: risk factors and protective effects of hormonal therapy and nutritional status[J]. Arch Osteoporos, 2025, 20(1): 83.
[18] CHUNG J H, HWANG H J, SHIN H Y, et al.Association between sarcopenic obesity and bone mineral density in middle-aged and elderly Korean[J]. Ann Nutr Metab, 2016, 68(2): 77-84.
[19] AHMADINEZHAD M, MANSOURNIA M A, FAHIMFAR N, et al. Prevalence of osteosarcopenic obesity and related factors among Iranian older people: Bushehr Elderly Health (BEH) program[J]. Arch Osteoporos, 2023, 18(1): 137.
[20] HENG M W Y, CHAN A W D, MAN R E K, et al. Individual and combined associations of sarcopenia, osteoporosis and obesity with frailty in a multi-ethnic Asian older adult population[J]. BMC Geriatr, 2023, 23(1): 802.
[21] KELLY O J, GILMAN J C, BOSCHIERO D, et al.Osteosarcopenic obesity: current knowledge, revised identification criteria and treatment principles[J]. Nutrients, 2019, 11(4): 747.
[22] 陈恒亭, 马剑雄, 卢斌, 等. 骨量-肌量减少性肥胖综合征与骨折关系的研究进展[J]. 中华老年医学杂志, 2018, 37(3): 347-350.
[23] TAO J, LI H, WANG H, et al.Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity[J]. Osteoporos Int, 2024, 35(12): 2087-2098.
[24] LIU Y, LIU Y, HUANG Y, et al. The effect of overweight or obesity on osteoporosis:a systematic review and meta-analysis[J]. Clin Nutr, 2023, 42(12): 2457-2467.
[25] 唐楠, 高远, 苏清清, 等. 老年骨质疏松患者再骨折影响因素分析及护理对策[J]. 中华护理杂志, 2025, 60(6): 710-716.
[26] KIM G, KIM J H. Impact of skeletal muscle mass on metabolic health[J]. Endocrinol Metab: Seoul, 2020, 35(1): 1-6.
[27] SANTHANAM L, LIU G, JANDU S, et al. Skeleton-secreted PDGF-BB mediates arterial stiffening[J]. J Clin Invest, 2021, 131(20): e147116.
[28] 张永政, 王荷晴, 崔立敏. 骨量-肌量减少性肥胖与衰弱相关性研究进展[J]. 护理研究, 2025, 39(13): 2307-2311.
[29] DOBRE M Z, VIRGOLICI B, CIOARCÃ-NEDELCU R. Lipidhormones at the intersection of metabolic imbalances and endocrine disorders[J]. Curr Issues Mol Biol, 2025, 47(7): 565.
[30] MACLEOD M, PRICE J, TSONOU E, et al. Adipose-derived extracellular vesicles and intercellular crosstalk with skeletal muscle: implications for sarcopenic obesity and metabolic dysregulation[J]. Obes Rev, 2026, 27(1): 1-22.
[31] LU L, TIAN L. Postmenopausal osteoporosis coexisting with sarcopenia: the role and mechanisms of estrogen[J]. J Endocrinol, 2023, 259(1): e230116.
[32] MCCOSKEY M, VERNON N. Male reproductive endocrine disorders[J]. Prim Care, 2024, 51(3): 455-466.
[33] NOBOA M E R, TSKHAKAIA I, ANDREWS J S. Comorbidities in idiopathic inflammatory myopathies: population-based evidence on risk subgroups and implications for delivery of care[J]. Curr Opin Rheumatol, 2026, 38(2): 76-82.
[34] DELONG A, FRIEDMAN M A, TUCKER S M, et al. Protective effects of controlled mechanical loading of bone in C57BL6/J mice subject to disuse[J]. JBMR Plus, 2019, 4(3): e10322.
[35] DAMLUJI A A, ALFARAIDHY M, ALHAJRI N, et al. Sarcopenia and cardiovascular diseases[J]. Circulation, 2023, 147(20): 1534-1553.
[36] VALLEJO J A, GRAY M, KLUMP J, et al. Bone mechanical loading reduces heart rate and increases heart rate variability in mice[J]. Bone Rep, 2025, 25: 101844.
[37] ILICH J Z, POKIMICA B, RISTIĆ-MEDIĆ D, et al.Osteosarcopenic adiposity (OSA) phenotype and its connection with cardiometabolic disorders: is there a cause-and-effect?[J]. Ageing Res Rev, 2024, 98: 102326.
[38] 陈兴才, 孔存青, 徐林, 等. 骨质疏松性少肌性肥胖综合征的诊断、治疗及相关影响因素[J]. 中国组织工程研究, 2020, 24(11): 1777-1782.
[39] HAMASAKI H. Obesity paradox in individuals with type 1 diabetes[J]. Front Clin Diabetes Healthc, 2025, 6: 1670312.
[40] ALEBNA P L, MEHTA A, YEHYA A, et al. Update on obesity, the obesity paradox, and obesity management in heart failure[J]. Prog Cardiovasc Dis, 2024, 82: 34-42.